The Fed Backs Your Portfolio

By Ray BlancoPosted June 18, 2020

The federal government has money burning a hole in its pocket… And that’s very good for our portfolio! The Trump administration is preparing a proposal to spend a whopping $1 trillion on infrastructure. It’s not just to jump-start a COVID-19-ravaged economy, either…

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication(s) below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.

Technology Profits Confidential Pro

Ray Blanco’s VIP Tech Advantage

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, Ray Blanco’s FDA Trader, Penny Pot Profits, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco

Our Satellite Co. Is Winning the Space Race

By Ray BlancoPosted June 17, 2016

We've become so used to ubiquitous internet access that we demand it everywhere. That includes while traveling 550 miles per hour 36,000 feet above the middle of the Atlantic. Airlines are in the business of more than just moving warm bodies at high speeds from one place to another. They are in the business of doing so in a way that makes their customers happy... at least happy enough to keep flying with a particular carrier.

Qualcomm Versus Apple: Game, Set, Match.

By Ray BlancoPosted April 19, 2019

The U.S. and the West in general are in a 5G race with China. The stakes are huge. 5G will enable new technologies, the shape of which we don’t even know yet…

New Data From Amicus Therapeutics

By Ray BlancoPosted February 15, 2013

I have some news today, headed by recent data from Amicus Therapeutics. The company has seen its share price drop after a placebo group in a study for its lead program showed an unusual amount of improvement. That, in turn, meant that the active arm in the trial didn't show a statistical benefit.

Vertex Races Ahead With New Hepatitis Cures

By Ray BlancoPosted February 24, 2012

The race for an all-oral hepatitis C cure continues to heat up. As you know, Vertex Pharmaceuticals made hepatitis treatment history in 2011 when Incivek became one of the two new hepatitis C therapies that were the first to be introduced in many years. To date, Incivek has dominated its competitors because of evidence of greater efficacy, and has enjoyed one of the most successful drug launches in history.

Tech Investing Opportunities Will Abound in 2015

By Ray BlancoPosted January 16, 2015

It's been a tough year so far for stocks, but you wouldn't have known it last week at the Consumer Electronics Show in Last Vegas. I was one of the 170,000 people who attended, and there was a great deal of excitement over the cutting-edge technologies on display. I checked out everything from the newest in appliances and televisions, to robotics, 3-D printers, wearable electronics, self-driving cars... the list is a long one.

What to Make of This Market, Plus Portfolio Updates

By Ray BlancoPosted January 15, 2016

January is often a good time for tech and biotech stocks…but not this year.

Login